Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development

por van Mierlo, Trevor, Fournier, Rachel, Ingham, Michael
Publicado 2015

The association between US Food and Drug Administration−expedited review designations and health plan specialty drug coverage

por Panzer, Ari D, Ingham, Michael, Martin, Silas, Chambers, James D
Publicado 2023

Predicting Pre-emptive Discussions of Biologic Treatment: Results from an Openness and Preference Survey of Inflammatory Bowel Disease Patients and Their Prescribers

por Kariburyo, M. Furaha, Xie, Lin, Teeple, Amanda, Tan, Haoran, Ingham, Michael
Publicado 2017

Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USA

por Singhal, Mukul, Tan, Hiangkiat, Coleman, Craig I, Han, Michelle, Nguyen, Chi, Ingham, Michael
Publicado 2019

Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis

por Bolge, Susan C, Eldridge, Helen M, Lofland, Jennifer H, Ravin, Caitlin, Hart, Philip J, Ingham, Michael P
Publicado 2017

The impact of non-medical switching among ambulatory patients: an updated systematic literature review

por Weeda, Erin R., Nguyen, Elaine, Martin, Silas, Ingham, Michael, Sobieraj, Diana M., Bookhart, Brahim K., Coleman, Craig I.
Publicado 2019